Glenmark Pharmaceuticals
GLENMARK.NS
#2749
Rank
ยฃ3.93 B
Marketcap
ยฃ13.93
Share price
0.80%
Change (1 day)
87.26%
Change (1 year)

Glenmark Pharmaceuticals (GLENMARK.NS) - Cash on Hand

Cash on Hand as of March 2024 : ยฃ0.17 Billion

According to Glenmark Pharmaceuticals 's latest financial reports the company has ยฃ0.17 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Glenmark Pharmaceuticals - Cash on Hand chart (from 2012 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-03-31ยฃ0.14 B-0.68%
2022-03-31ยฃ0.14 B20.44%
2021-03-31ยฃ0.12 B-4.9%
2020-03-31ยฃ0.12 B1.11%
2019-03-31ยฃ0.12 B-19.17%
2018-03-31ยฃ0.15 B3.04%
2017-03-31ยฃ0.15 B67.18%
2016-03-31ยฃ89.84 M7.39%
2015-03-31ยฃ83.66 M2.92%
2014-03-31ยฃ81.28 M9.17%
2013-03-31ยฃ74.46 M82.96%
2012-03-31ยฃ40.69 M49.75%
2011-03-31ยฃ27.17 M72.74%
2010-03-31ยฃ15.73 M60.34%
2009-03-31ยฃ9.81 M-50.38%
2008-03-31ยฃ19.77 M58.44%
2007-03-31ยฃ12.48 M-8.55%
2006-03-31ยฃ13.64 M-11.64%
2005-03-31ยฃ15.44 M1418.47%
2004-03-31ยฃ1.01 M